Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MDM4 | O15151 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 3/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29129196 | 1.00 | KMT2A (0.57) | KMT2AMDM4TP53CASP3ANPEP | |
| SCHEMBL29613497 | 0.91 | KMT2A (0.53) | KMT2ACASP3ANPEPTLR2MDM2 | |
| SCHEMBL29681768 | 0.91 | KMT2A (0.55) | KMT2ATLR2MDM2 | |
| SCHEMBL29613477 | 0.90 | KMT2A (0.52) | KMT2AANPEP | |
| SCHEMBL29129039 | 0.90 | KMT2A (0.52) | KMT2ATLR2MDM2 | |
| SCHEMBL29129046 | 0.90 | KMT2A (0.52) | KMT2ATLR2MDM2 | |
| SCHEMBL23286117 | 0.87 | KMT2A (0.55) | KMT2ATLR2MDM2 | |
| SCHEMBL2089280 | 0.87 | KMT2A (0.67) | KMT2AMDM4TP53CASP3ANPEP | |
| SCHEMBL10052316 | 0.87 | KMT2A (0.67) | KMT2AMDM4TP53CASP3ANPEP | |
| SCHEMBL29398504 | 0.87 | KMT2A (0.67) | KMT2AMDM4TP53CASP3ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279636-A | Methods and compounds for modulating myotonic muscular dystrophy type 1 | 设计治疗公司 | 2023-12-22 | — | — | CN | disclosed |